The presence of very high titers of antithyroglobulin antibodies and antithyroid peroxidase antibodies is highly suggestive of which disorder?

Enhance your knowledge with the Ciulla Clinical Chemistry Test. Study with interactive quizzes, featuring flashcards and multiple-choice questions. Each question offers hints and explanations for better understanding. Prepare effectively and excel in your exam!

Multiple Choice

The presence of very high titers of antithyroglobulin antibodies and antithyroid peroxidase antibodies is highly suggestive of which disorder?

Explanation:
Elevated autoantibodies against thyroid components point to autoimmune attack on the gland. In Hashimoto thyroiditis, the immune system produces high levels of antibodies to thyroid peroxidase and thyroglobulin, reflecting autoimmune destruction of thyroid tissue. This pattern is strongly associated with Hashimoto’s and helps distinguish it from other thyroid issues. Pernicious anemia is autoimmune but targets gastric factors (like intrinsic factor or parietal cells), not thyroid proteins, so its antibody profile wouldn’t center on TgAb and TPOAb. Structural thyroid problems such as multinodular goiter or a thyroid adenoma don’t inherently involve autoimmune antibodies to thyroid proteins.

Elevated autoantibodies against thyroid components point to autoimmune attack on the gland. In Hashimoto thyroiditis, the immune system produces high levels of antibodies to thyroid peroxidase and thyroglobulin, reflecting autoimmune destruction of thyroid tissue. This pattern is strongly associated with Hashimoto’s and helps distinguish it from other thyroid issues. Pernicious anemia is autoimmune but targets gastric factors (like intrinsic factor or parietal cells), not thyroid proteins, so its antibody profile wouldn’t center on TgAb and TPOAb. Structural thyroid problems such as multinodular goiter or a thyroid adenoma don’t inherently involve autoimmune antibodies to thyroid proteins.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy